Domenico Angellotti
@DomAngellotti
Followers
129
Following
411
Media
5
Statuses
51
MD | Cardiologist | PhD candidate
Berne, Switzerland
Joined December 2022
Emerging evidence supporting transcatheter tricuspid interventions https://t.co/ZpsKsisEeB
💬 Viewpoint: RCTs in tricuspid regurgitation indicate that transcatheter therapies can enhance quality of life and reduce certain clinical events compared to medical therapy. https://t.co/bXdqud9zhZ
0
2
5
💬 Viewpoint: RCTs in tricuspid regurgitation indicate that transcatheter therapies can enhance quality of life and reduce certain clinical events compared to medical therapy. https://t.co/bXdqud9zhZ
0
5
18
In this analysis of >1,000 TAVI patients, we demonstrate that underexpansion of balloon-expandable transcatheter aortic valves, as assessed by fluoroscopy, is associated with an increased risk of hemodynamic valve deterioration at mid-term follow-up. https://t.co/8imr7NRBd2
0
29
102
The extent of cardiac damage significantly affects 10-year survival of patients with moderate and severe aortic stenosis. Cardiac damage staging might be as important as aortic stenosis grading in defining the prognosis of patients with aortic stenosis. https://t.co/BMu2HmsuLI
1
12
42
Procedural factors determine transcatheter aortic valve performance. The CODE framework integrates key parameters to systematically optimize TAVR outcomes. https://t.co/tShLeOxMMM
@JACCJournals @DomAngellotti
2
43
142
#CT #imaging suggests similar #eligibility x #TTVI & comparable TV anatomical phenotypes across severe, massive, and torrential #TR ! A pleasure to co-first author wth @DomAngellotti P. Kampaktsis, led by @OKhaliqueMD & @FabienPraz @joan_bartc @hahn_rt 🙏 @SpringerNature
3
7
18
TRISCEND II subanalysis showed greater benefit of TTVR in massive/torrential TR, suggesting this may be the target population ( https://t.co/OLkOdJCnH4). In our paper just published, massive/torrential TR did not reduce TTVI eligibility vs severe TR ( https://t.co/s8wVRaNOH3)
2
7
18
A personalized DAPT was superior to standard DAPT after PCI.📌Here are the slides presented at: #ESCCongress @mmamas1973 @mirvatalasnag @rwyeh @djc795 @CMichaelGibson @SripalBangalore @Costa_F_8 @pash22 @Ahmed43101178 @Hragy @SABOURETCardio @drjohnm @espogiov @JACCJournals
In patients undergoing #PCI, a personalized #DAPT duration from 3 to 24 months led to a lowered risk of net adverse clinical events than standard care consisting of 12 months of DAPT. https://t.co/N1YFaMUkku
#JACC #ESCCongress #WCCardio @piccoloraf @DFCapodanno
6
29
65
The 2025 ESC/EACTS guidelines on the management of valvular heart disease have just been released, with an important update: the age threshold for the Heart Team to consider TAVI instead of surgical intervention has been lowered from 75 to 70 years in patients with tricuspid
6
92
211
We found no sex-based differences in the treatment effect of antithrombotic therapies across 33 RCTs (N=274,433): sex should not guide selection of antithrombotic tx in pts with established CAD. @mirvatalasnag @WomenAs1 @mmamas1973 @DLBHATTMD @bmj_latest @djc795 @cpgale3 @Hragy
4
7
21
Are you performing right cath after TTVR? EJHF: First insights into the impact of TR elimination on right heart: Immediate RAP reduction ⬇️ Increased systolic RV/PA pressure⬆️ and PAPi ⬆️ Data From Bern by Fabien Praz 🔗 https://t.co/W0gxh7CxyR
@EJHFEiC #CardioTwitter
0
9
15
📊 Real-world data on TTVR unveiled today at #NYValves2025 and simultaneously published in JACC: Cardiovascular Interventions. https://t.co/tWKkgClYhU
#CardioResearch
0
5
11
#NYValves2025 brings together leaders in SHD: interventionalists, imagers, surgeons, & HF specialists. 📚 Browse new #JACCJournals research published to coincide w/ meeting presentations here: https://t.co/Jhl34tjhoi
#JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports
1
9
24
Non-coaxial transcatheter aortic valve deployment relative to the native annulus is associated with impaired valve early safety and increased risk of bioprosthetic valve failure 1 year after TAVR. https://t.co/zIezMCahf8
4
36
107
1. #EAPCI @escardio Summit in Napoli 🇮🇹 #brainstorming with ESC National Societies & WG on #Education 🌸Day 1️⃣ ⭐️Research ⭐️Scientific Documents ⭐️Certification ⭐️Congress & Sessions at NS #EAPCIfamily
1
14
50
Access free for 50 days our SOTA https://t.co/frNjlmGNrH The Last Decade in Tricuspid Regurgitation: How Imaging Shaped a Field @lpbadano @denisamuraru @FabienPraz @NAjmoneMarsan @VDelgadoGarcia @j_hausleiter @JACCJournals @escardio @ACCinTouch
4
66
153
Just published in @JACCJournals : Severe trans- & para-valvular MR post-healed endocarditis managed with closure of mitral annulus cavity with a nitinol occluder then Tendyne mitral valve implantation It won best case at #PCRLV 2024. @FabienPraz @DomAngellotti @SelimMosbahi
4
9
33
ELASTA-Clip followed by transapical TMVR is a less invasive Tx for patients with failed M-TEER, with encouraging early results in carefully selected Pts. Preventing PVL and stroke is crucial. Larger, long-term studies are needed @JACCJournals
https://t.co/sEV2xplJtB
0
7
15
🔴Transcatheter Tricuspid Valve Replacement ⤵️ JACC State-of-the-Art #2025Review #OpenAccess 🔹 https://t.co/NF48ZhhPKM
#POCUS #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX
0
20
76